Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients

首页> 外文期刊>Journal of Nuclear Cardiology >Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients

【24h】

Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients

机译：Regadenoson是一种安全且耐受良好的药理学应激药物，可用于心脏移植术后患者的心肌灌注成像

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background The safety and tolerability of regadenoson (REG), a newer adenosine A_2a receptor agonist, has not been tested in orthotopic heart transplant (OHT) patients.

机译：背景技术尚未在原位心脏移植（OHT）患者中测试新型腺苷A _{2a 受体激动剂REGAdenoson（REG）的安全性和耐受性。}

著录项

来源
《Journal of Nuclear Cardiology》 |2011年第4期|p.628-633|共6页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients. [J] . Cavalcante JL, Barboza J, Ananthasubramaniam K Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology . 2011,第4期

机译：Regadenoson是一种安全且耐受良好的药理学应激药物，可用于心脏移植术后患者的心肌灌注成像。
2. Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis. [J] . Palani G, Husain Z, Salinas RC, Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology . 2011,第4期

机译：在没有进行血液透析的慢性肾脏疾病患者中，regadenoson作为用于心肌灌注显像的药理学应激剂的安全性。
3. Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis [J] . Journal of Nuclear Cardiology . 2011,第4期

机译：在没有进行血液透析的慢性肾脏病患者中，regadenoson作为药理学应激剂用于心肌灌注显像的安全性
4. Safety and efficacy of Regadenoson in myocardial perfusion imaging (MPI) stress tests: A review [C] . Ambereen Ahmed Conference on quantitative phase imaging . 2018

机译：Regadenoson在心肌灌注成像（MPI）压力测试中的安全性和有效性：综述
5. The Significance of Post-stress Decrease in Left Ventricular Ejection Fraction in Patients Undergoing Regadenoson Stress Gated SPECT Myocardial Perfusion Imaging [D] . Gomez Valencia, Javier. 2018

机译：左心室喷射部分在接受Regadenoson胁迫凸起的SPECT心肌灌注成像患者中左心室喷射部分后应力降低的重要性
6. Regadenoson a Novel Pharmacologic Stress Agent for Use in Myocardial Perfusion Imaging Does Not Have a Direct Effect on the QT Interval in Conscious Dogs [O] . Gong Zhao, Sabrina Serpllion, John Shryock, -1

机译：Regadenoson是一种用于心肌灌注显像的新型药理学应激药物对清醒犬的QT间隔没有直接影响
7. IS STRESS MYOCARDIAL PERFUSION IMAGING WITH REGADENOSON, A NEW PHARMACOLOGIC STRESS AGENT, SAFE IN ORTHOTOPIC HEART TRANSPLANT PATIENTS? FIRST REPORT OF REGADENOSON, A SELECTIVE A2A RECEPTOR AGONIST IN THE HEART TRANSPLANT POPULATION [O] . Cavalcante Joao L., Al-Mallah Mouaz, Tita Cristina, 2010

机译：新型心律失常药物REGADENOSON对应激性心肌灌注成像是否有效，对正直心脏移植患者的安全性？心脏移植人群中选择性A2A受体激动剂REGADENOSON的首次报告

Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅